(Q34446288)

English

Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

immunologic adjuvant

1 reference

based on heuristic

inferred from title

author name string

Kim EM

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sivanandham M

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Stavropoulos CI

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Bartolucci AA

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Wallack MK

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

53-59

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell clones that react against autologous human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The development of new immunotherapies for the treatment of cancer using interleukin-2. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo effects of combination treatment with recombinant interferon-gamma and -alpha in metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Virus Augmentation of The Antigenicity of Tumor Cell

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of osteosarcoma patients with virus-modified tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy With Viral Oncolysates for Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A new approach in specific, active immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Further investigations on the mode of entry of vaccinia virus into cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900020-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-7404(01)00020-2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34446288&oldid=2039651694"